Page 576 - Cardiac Nursing

Apt
52
52
ara
9/0
9/2
009
e 5
M
9 A
8:2
P
p53
g
P
0-c
K34
54.
23_
7-5
54.
L L LWB
LWB K34 0-c 23_ p53 7-5 54. qxd 0 9/0 9/2 009 0 0 8:2 9 A M P a a g e 5 52 Apt ara
0
qxd
K34
LWBK340-c23_23_p537-554.qxd 09/09/2009 08:29 AM Page 552 Aptara
552 PA R T I V / Pathophysiology and Management of Heart Disease
5. Boden, W. E., O’Rourke, R. A., Teo, K. K., et al. (2007). Optimal med- myocardial infarction: 30-day results from a multicenter randomized
ical therapy with or without PCI for stable coronary disease. New England study. Journal of the American College of Cardiology, 48(2), 244–252.
6
6
Journal of Medicine, 356(15), 1503–1516. 24. Kaltoft, A., Bottcher, M., Nielsen, S. S., et al. (2006). Routine thrombec-
6. Jacobs, A. K. (2003). Coronary revascularization in women in 2003: Sex tomy in percutaneous coronary intervention for acute ST-segment-elevation
7
7
4
revisited. Circulation, 107(3), 375–377. myocardial infarction: A randomized, controlled trial. Circulation, 114(1),
4
7. Sedlis, S. P., Morrison, D. A., Lorin, J. D., et al. (2002). Percutaneous coro- 40–47.
nary intervention versus coronary bypass graft surgery for diabetic patients 25. V. Korn, H., Ohlow, M., Donev, S., et al. (2007). Export aspiration sys-
with unstable angina and risk factors for adverse outcomes with bypass: tem in patients with acute coronary syndrome and visible thrombus pro-
Outcome of diabetic patients in the AWESOME randomized trial and reg- vides no substantial benefit. Catheterization and Cardiovascular Interven-
istry. Journal of the American College of Cardiology, 40(9), 1555–1566. tions, 70(1), 35–42.
8. The Bypass Angioplasty Revascularization Investigation (BARI) Investiga- 26. Silva, J. A., Ramee, S. R., Cohen, D. J., et al. (2001). Rheolytic thrombec-
tors. (1996). Comparison of coronary bypass surgery with angioplasty in tomy during percutaneous revascularization for acute myocardial infarc-
patients with multivessel disease. The Bypass Angioplasty Revasculariza- tion: Experience with the AngioJet catheter. American Heart Journal,
tion Investigation (BARI) Investigators. New England Journal of Medicine, 141(3), 353–359.
335(4), 217–225. 27. Colombo, A., Stankovic, G., & Moses, J. W. (2002). Selection of coronary
9. The Bypass Angioplasty Revascularization Investigation (BARI) Investiga- stents. Journal of the American College of Cardiology, 40(6), 1021–1033.
tors. (2000). Seven-year outcome in the Bypass Angioplasty Revascular- 28. Sigwart, U., Puel, J., Mirkovitch, V., et al. (1987). Intravascular stents to pre-
ization Investigation (BARI) by treatment and diabetic status. Journal of vent occlusion and restenosis after transluminal angioplasty. New England
6
the American College of Cardiology, 35(5), 1122–1129. Journal of Medicine, 316(12), 701–706.
6
10. Baumgart, D., Klauss, V., Baer, F., et al. (2007). One-year results of the 29. Roubin, G. S., Cannon, A. D., Agrawal, S. K., et al. (1992). Intracoronary
SCORPIUS study: A German multicenter investigation on the effective- stenting for acute and threatened closure complicating percutaneous trans-
ness of sirolimus-eluting stents in diabetic patients. Journal of the American luminal coronary angioplasty. Circulation, 85(3), 916–927.
College of Cardiology, 50(17), 1627–1634. 30. Fischman, D. L., Leon, M. B., Baim, D. S., et al. (1994). A randomized
11. Anderson, J. L., Adams, C. D., Antman, E. M., et al. (2007). ACC/AHA comparison of coronary-stent placement and balloon angioplasty in the
2007 guidelines for the management of patients with unstable treatment of coronary artery disease. Stent Restenosis Study Investigators.
angina/non-ST-Elevation myocardial infarction: A report of the American New England Journal of Medicine, 331(8), 496–501.
College of Cardiology/American Heart Association Task Force on Practice 31. Serruys, P. W., de Jaegere, P., Kiemeneij, F., et al. (1994). A comparison of
Guidelines (Writing Committee to Revise the 2002 Guidelines for the balloon-expandable–stent implantation with balloon angioplasty in pa-
Management of Patients With Unstable Angina/Non-ST-Elevation My- tients with coronary artery disease. Benestent Study Group. New England
ocardial Infarction) developed in collaboration with the American College Journal of Medicine, 331(8), 489–495.
of Emergency Physicians, the Society for Cardiovascular Angiography and 32. Klein, L. W. (2006). Are drug-eluting stents the preferred treatment for
Interventions, and the Society of Thoracic Surgeons endorsed by the multivessel coronary artery disease? Journal of the American College of
7
7
American Association of Cardiovascular and Pulmonary Rehabilitation and Cardiology, 47(1), 22–26.
the Society for Academic Emergency Medicine. Journal of the American 33. Weisz, G., Leon, M. B., Holmes, D. R., Jr., et al. (2006). Two-year out-
College of Cardiology, 50(7), e1–e157. comes after sirolimus-eluting stent implantation: Results from the
12. Wali, A. (2007). Multivessel stenting in the current DES era. Cardiac In- Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS)
terventions Today, 1(1), 39–42. trial. Journal of the American College of Cardiology, 47(7), 1350–1355.
7
7
13. Hannan, E. L., Wu, C., Walford, G., et al. (2008). Drug-eluting stents vs. 34. Serruys, P. W., Kutryk, M. J., & Ong, A. T. (2006). Coronary-artery
coronary-artery bypass grafting in multivessel coronary disease. New Eng- stents. New England Journal of Medicine, 354(5), 483–495.
land Journal of Medicine, 358(4), 331–341. 35. Moses, J. W., Leon, M. B., Popma, J. J., et al. (2003). Sirolimus-eluting
14. Wiemer, M., Langer, C., Kottmann, T., et al. (2007). Outcome in the eld- stents versus standard stents in patients with stenosis in a native coronary
erly undergoing percutaneous coronary intervention with sirolimus-eluting artery. New England Journal of Medicine, 349(14), 1315–1323.
stents: Results from the prospective multicenter German Cypher Stent Reg- 36. Grube, E., Silber, S., Hauptmann, K. E., et al. (2003). TAXUS I: Six- and
istry. American Heart Journal, 154(4), 682–687. twelve-month results from a randomized, double-blind trial on a slow-release
15. Dotter, C. T., & Judkins, M. P. (1989). Transluminal treatment of arte- paclitaxel-eluting stent for de novo coronary lesions. Circulation, 107(1),
7
7
riosclerotic obstruction. Description of a new technic and a preliminary 38–42.
report of its application. 1964. Radiology, 172(3, Pt. 2), 904–920. 37. Schomig, A., Dibra, A., Windecker, S., et al. (2007). A meta-analysis of
16. Kondo, T., Kawaguchi, K., Awaji, Y., et al. (1997). Immediate and chronic 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting
results of cutting balloon angioplasty: A matched comparison with con- stents in patients with coronary artery disease. Journal of the American
ventional angioplasty. Clinical Cardiology, 20(5), 459–463. College of Cardiology, 50(14), 1373–1380.
17. Silber, S., Albertsson, P., Aviles, F. F., et al. (2005). Guidelines for percu- 38. Cohan, R. H., Ellis, J. H., & Dunnick, N. R. (1995). Use of low-osmo-
taneous coronary interventions. The Task Force for Percutaneous Coro- lar agents and premedication to reduce the frequency of adverse reactions
nary Interventions of the European Society of Cardiology. European Heart to radiographic contrast media: A survey of the Society of Uroradiology.
6
6
Journal, 26(8), 804–847. Radiology, 194(2), 357–364.
18. Bittl, J. A., Chew, D. P., Topol, E. J., et al. (2004). Meta-analysis of ran- 39. Briguori, C., Airoldi, F., D’Andrea, D., et al. (2007). Renal Insufficiency Fol-
domized trials of percutaneous transluminal coronary angioplasty versus lowing Contrast Media Administration Trial (REMEDIAL): A randomized
atherectomy, cutting balloon atherotomy, or laser angioplasty. Journal of comparison of 3 preventive strategies. Circulation, 115(10), 1211–1217.
the American College of Cardiology, 43(6), 936–942. 40. Antman, E. M. (2003). Should bivalirudin replace heparin during percu-
19. Topol, E. J., Leya, F., Pinkerton, C. A., et al. (1993). A comparison of direc- taneous coronary interventions? JAMA, 289(7), 903–905.
tional atherectomy with coronary angioplasty in patients with coronary artery 41. Lincoff, A. M., Bittl, J. A., Harrington, R. A., et al. (2003). Bivalirudin
disease. The CAVEAT Study Group. New England Journal of Medicine, and provisional GP IIb/IIIa blockade compared with heparin and planned
329(4), 221–227. GP IIb/IIIa blockade during percutaneous coronary intervention:
20. Holmes, D. R., Jr., Topol, E. J., Califf, R. M., et al. (1995). A multicen- REPLACE-2 randomized trial. JAMA, 289(7), 853–863.
ter, randomized trial of coronary angioplasty versus directional atherec- 42. Juran, N. B., Rouse, C. L., Smith, D. D., et al. (1999). Nursing interven-
tomy for patients with saphenous vein bypass graft lesions. CAVEAT-II tions to decrease bleeding at the femoral access site after percutaneous
Investigators. Circulation, 91(7), 1966–1974. coronary intervention. SANDBAG Nursing Coordinators. Standards of
21. Teirstein, P. S., Warth, D. C., Haq, N., et al. (1991). High speed rotational Angioplasty Nursing Techniques to Diminish Bleeding Around the Groin.
coronary atherectomy for patients with diffuse coronary artery disease. American Journal of Critical Care, 8(5), 303–313.
Journal of the American College of Cardiology, 18(7), 1694–1701. 43. Landau, C., Lange, R. A., Glamann, D. B., et al. (1994). Vasovagal reactions
22. Dahm, J. B., Kuon, E., Vogelgesang, D., et al. (2002). Relation of degree in the cardiac catheterization laboratory. American Journal of Cardiology, 73,
of laser debulking of in-stent restenosis as a predictor of restenosis rate. 95–97.
American Journal of Cardiology, 90(1), 68–70. 44. Dauerman, H. L., Applegate, R. J., & Cohen, D. J. (2007). Vascular closure
23. Ali, A., Cox, D., Dib, N., et al. (2006). Rheolytic thrombectomy with per- devices: The second decade. Journal of the American College of Cardiology,
cutaneous coronary intervention for infarct size reduction in acute 50(17), 1617–1626.